Cargando…
2514. Single Ascending Dose Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intramuscular CD388, a Novel Long-acting Drug-Fc Conjugate for Universal Prevention of Seasonal and Pandemic Influenza
BACKGROUND: CD388 is a novel antiviral drug-Fc conjugate (DFC) designed to deliver universal prevention of seasonal and pandemic influenza. Nonclinical studies have shown CD388 was effective prophylactically against a wide range of seasonal and pandemic influenza A and B strains in lethal and nonlet...
Autores principales: | Flanagan, Shawn, Ong, Voon, Baguet, Tristan, Rojas, Roxana E, Wang, Sy-Shi, Equils, Ozlem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678303/ http://dx.doi.org/10.1093/ofid/ofad500.2132 |
Ejemplares similares
-
2514: Governance for a decentralized informatics academic environment
por: Fogg, Thomas, et al.
Publicado: (2018) -
2116. Efficacy of CD388, a Novel Drug Fc-Conjugate (DFC), is Driven by the Small Molecule Neuraminidase Inhibitor (NAI)
por: Döhrmann, Simon, et al.
Publicado: (2023) -
2514 Disparities in care among patients presenting to the emergency department for nephrolithiasis
por: Schoenfeld, Daniel, et al.
Publicado: (2018) -
2514. Pediatric Medically Attended Shingles in Alberta, Canada 2016; Preliminary Results
por: Booth, Stephanie, et al.
Publicado: (2018) -
Subcutaneous Sarcoidosis with Underlying Intramuscular Granuloma
por: Ohashi, Takenobu, et al.
Publicado: (2015)